Increased osteoclast activity in the presence of increased homocysteine concentrations.
about
Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implicationsHydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca(2+) channel sulfhydrationVitamins and bone health: beyond calcium and vitamin D.Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidenceThe role of homocysteine in bone remodelingHomocysteine modifies structural and functional properties of fibronectin and interferes with the fibronectin-fibrillin-1 interaction.Effect of B vitamin (folate, B6, and B12) supplementation on osteoporotic fracture and bone turnover markers: a meta-analysis.B vitamins, homocysteine and bone health.B-vitamins and bone health--a review of the current evidence.The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.Homocysteine--a newly recognised risk factor for osteoporosis.Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analysesLow bone mineral density is a common finding in patients with homocystinuria.The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review.Bone mass and vitamin D levels in Parkinson's disease: is there any difference between genders?Association between Homocysteine and Bone Mineral Density according to Age and Sex in Healthy Adults.Stimulation of osteoblast activity by homocysteine.B-vitamins and bone in health and disease: the current evidence.The Role of B-Vitamins in Bone Health and Disease in Older Adults.B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials.Milk-cereal and whole-grain dietary patterns protect against low bone mineral density among male adolescents and young adults.Homocysteine as a Pathological Biomarker for Bone Disease.Excess dietary methionine does not affect fracture healing in mice.Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis.Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis.Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease.Homocysteine research--where do we stand and where are we going?The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial.Vitamin B12, bone mineral density and fracture risk in adults: A systematic review.Chemical Biology of H2S Signaling through Persulfidation.The Assessment of Bone Regulatory Pathways, Bone Turnover, and Bone Mineral Density in Vegetarian and Omnivorous Children.3'-UTR Polymorphisms of MTHFR and TS Associated with Osteoporotic Vertebral Compression Fracture Susceptibility in Postmenopausal Women.Relation of Bone Mineral Density with Homocysteine and Cathepsin K levels in Postmenopausal Women.
P2860
Q26824690-4A25239D-0D1A-4B50-83EC-A6EFEA3618D8Q33849378-50961EF8-8367-4A8E-9FE0-3DE63D1DA908Q34028824-9D91E8AA-D5A3-4539-AB78-07CFEBE227F5Q34089595-B0FD580F-F602-4D76-98FC-D25F8CA55227Q34330278-C2F2B34B-B9B2-4377-89B3-EB57A43D9464Q35038315-8AAF176B-45E9-461A-85ED-50F0D09971E4Q35259493-3F84D4E6-92F7-4FFB-BBF1-5EC49DE7CD09Q35585842-3CC3C001-31D2-4283-8C42-98C4171369CFQ35658071-98352C9D-D56A-462B-A744-F406F681B7FEQ35752594-7CB55AD3-71B6-4975-BAB3-B76936148345Q36273347-3A66436F-9A60-489B-98DD-6832C2B14482Q36664131-AC8407FD-C48B-4859-B539-3EA12B983A59Q36677886-14F4F207-F946-43AB-BC09-D4FD8156CACEQ37027538-E7682AF2-EF31-4E07-8DCF-667F814745A4Q37232448-FF4A670F-C829-4934-9EAC-2C0C1E477410Q37247117-17AAD3ED-290E-4182-B0BC-98993EE5566CQ37398273-DEF2223A-6A4B-4107-A3C7-BF64D54DB707Q38191360-5316FD75-4762-4F85-9A26-C21B0925A370Q38504773-0A093DF1-FEBE-4C98-8720-0B39DD537B38Q38748834-441F6BA7-0A2B-4E0B-9632-C5D3CEFF3187Q38754731-6DDD3C84-EE74-46ED-8CCA-06C2A0CCBAFFQ39012193-50415750-1586-4CC0-B9F9-B2812E133F1FQ43108176-94FC0233-09C6-4008-B5E0-48A9EAB275B3Q43117573-E98AE09E-61D0-4543-9B78-2B53030CDACBQ43230220-C39ECA5E-DB48-4613-A6F0-65F9E80C856EQ43235821-7254CFE0-7498-48C3-9970-EB467E805947Q46729795-3FF7D24E-46D2-4B91-81C2-B38FA92AF05EQ46894818-3D74EE57-AD6C-40A6-BC70-15757AA611D4Q47312295-D950D95E-AC96-4874-B25E-6319AB647400Q47430972-60C98A78-9511-4DC7-8946-3F3EC5FEC1F8Q50133867-CF62661A-5ED6-4404-9B67-FC1A6EDEEADDQ51763541-82711E4C-9D75-4201-B060-F54A8EE07CF8Q55312636-987DD026-C48F-4E57-AF70-F24DB264B270
P2860
Increased osteoclast activity in the presence of increased homocysteine concentrations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased osteoclast activity in the presence of increased homocysteine concentrations.
@en
type
label
Increased osteoclast activity in the presence of increased homocysteine concentrations.
@en
prefLabel
Increased osteoclast activity in the presence of increased homocysteine concentrations.
@en
P2093
P1433
P1476
Increased osteoclast activity in the presence of increased homocysteine concentrations.
@en
P2093
Alberta Zallone
Markus Herrmann
Thomas Widmann
Wolfgang Herrmann
P304
P356
10.1373/CLINCHEM.2005.053363
P407
P577
2005-09-29T00:00:00Z